Purchase Order 36C25026P0471
- Not listed
- Roche Diagnostics Corporation received a $33,561.68 firm fixed-price delivery order from Veterans Integrated Service Network (VISN) 10, a component of the Department of Veterans Affairs, for Roche Diagnostic brand reagents and consumables supplies. The award, announced on March 1, 2026, is scheduled for completion by February 28, 2027, and will be performed at the contractor's facility in Castleton, Indiana. This is a competitive award with no set-aside designation, reflecting open competition...
- Roche Diagnostics Corporation received a $548,492.46 firm fixed-price purchase order from Veterans Integrated Service Network 22 (VISN 22), a civilian component of the Department of Veterans Affairs, for reagents and consumables. The contract was awarded on December 5, 2025, with an ultimate completion date of June 4, 2026, and will be performed at the contractor's facility in Castleton, Indiana. This award carries no set-aside designation, indicating open competition in the federal marketplace....
- Roche Diagnostics Corporation received a firm fixed-price delivery order valued at approximately $5.97 million from Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs, for the supply of reagents. The contract, awarded on September 1, 2023, extends through August 31, 2028, and will be performed in Castleton, Indiana. This delivery order operates as a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana, received a $1.04 million firm fixed-price Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network (VISN) 19 for GenMark EPLEX reagents and maintenance services. The contract was awarded without set-aside designation on December 30, 2024, with performance concluding by December 29, 2025. Services will be delivered to the Salt Lake City, Utah location supporting VISN 19's diagnostic laboratory...
- The Department of Veterans Affairs' Veterans Integrated Service Network 23 awarded Roche Diagnostics Corporation a delivery order valued at $190,494.82 on October 11, 2024, for microbiology reagents during the base period, with an ultimate completion date of September 30, 2025. This firm fixed-price contract, which includes a deobligation component, will be performed in Castleton, Indiana. The award carries no set-aside designation and represents the government's procurement of essential...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order valued at $216,158.41 to Roche Diagnostics Corporation for COBAS 6800 reagents and supplies. This firm fixed-price delivery order, issued on October 1, 2023, with completion targeted for September 30, 2024, supports laboratory diagnostic capabilities at the performance location in Castleton, Indiana. The award was made through open competition without set-aside designation, reflecting...
- Roche Diagnostics Corporation was awarded a delivery order valued at $186,088.66 by Veterans Integrated Service Network 6 (VISN 6) on October 1, 2023, for roche reagents and supplies. This firm fixed-price contract, which was not issued under a set-aside designation, has an ultimate completion date of September 30, 2024, and will be performed in Castleton, Indiana. The award represents a child order under VISN 6's larger indefinite delivery contract with Roche Diagnostics, which carries a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Roche Diagnostics Corporation a $159,303 purchase order contract to provide EPLEX reagents. The contract has a firm fixed price and performance will take place in Castleton, Indiana over a four month period from November 2023 through February 2024. As part of its mission to provide healthcare services to veterans, the VA-VHA will use these reagents, likely for diagnostic testing, to...
- Roche Diagnostics Corporation has been awarded a Blanket Purchase Agreement (BPA) call valued at $261,809.08 for molecular diagnostic viral testing reagents and supplies through Veterans Integrated Service Network 17 (VISN 17). The contract, awarded on October 3, 2024, with completion targeted for October 2, 2025, is a firm fixed-price vehicle under the Critical Analyzers, Laboratory General Services Administration Schedule (FSS-66-III). This award was made without set-aside designation,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2), awarded a delivery order to Roche Diagnostics Corporation on October 1, 2024, for reagents, supplies, and consumables supporting a Roche-manufactured COBAS 6800/8800 laboratory instrument. This firm fixed-price delivery order, valued at $45,712.48, is scheduled for completion by September 30, 2025, and will be performed at the contractor's facility in Castleton, Indiana. The award was made without set-aside...
Roche Diagnostics Corporation has been awarded a firm fixed-price purchase order valued at $33,453 by Veterans Integrated Service Network 10 (VISN 10) for GenMark ePlex reagents, with an ultimate completion date of March 20, 2027. This contract was awarded on March 21, 2026, without a set-aside designation, reflecting open competition. The reagents will be delivered to Castleton, Indiana, supporting VISN 10's diagnostic testing capabilities as part of the Department of Veterans Affairs' broader laboratory and clinical diagnostic infrastructure serving veterans across the network. This award represents a discrete purchase order under Roche Diagnostics' existing relationship with VISN 10, which includes a larger $2.0 million Blanket Purchase Agreement for COBAS 6800 testing services and maintenance extending through December 2030. Roche Diagnostics, a foreign-owned multinational corporation headquartered in Indianapolis, maintains an extensive federal contracting footprint across the Veterans Health Administration, Defense Health Agency, and other federal healthcare entities. The company supplies comprehensive diagnostic solutions including molecular analyzers, reagents, laboratory instruments, and associated clinical technologies. This ePlex reagents order fulfills specific testing requirements within VISN 10's diagnostic portfolio, contributing to the network's capacity to deliver laboratory medicine services to its veteran patient population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.5k | 3/20/26 |